Skip to content

Validity and Responsiveness of the Fugl-Meyer Assessment in Subacute Stroke Patients

Validity and Responsiveness of the Fugl-Meyer Assessment in Individuals With Subacute Stroke

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07508540
Acronym
FMA_val_resp
Enrollment
135
Registered
2026-04-02
Start date
2023-07-01
Completion date
2026-01-01
Last updated
2026-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

stroke, rehabilitation, Measurement Properties

Brief summary

This prospective multicenter study evaluated the construct validity and responsiveness of the Fugl-Meyer Assessment (FMA) in individuals with subacute stroke undergoing inpatient rehabilitation. A total of over 100 participants were assessed at admission and discharge using FMA alongside established clinical measures and patient-reported anchors.

Detailed description

This study aims to evaluate the construct validity and responsiveness of the Fugl-Meyer Assessment (FMA) in individuals with subacute stroke undergoing inpatient rehabilitation. The FMA is widely used to assess motor impairment after stroke; however, evidence on its responsiveness, particularly in subacute populations, remains limited. Participants with post-stroke hemiparesis are assessed at admission and discharge using the FMA, along with other clinical outcome measures. Construct validity is examined by testing predefined hypotheses on the association between FMA scores and measures of muscle strength and functional independence. Responsiveness is evaluated using both anchor-based and distribution-based approaches, including patient-reported and performance-based external criteria. The study focuses on both upper and lower limb subscales of the FMA. External anchors include a Global Rating of Change scale and functional ambulation measures, allowing a multidimensional interpretation of motor recovery. The ability of the FMA to detect clinically meaningful changes over time is quantified through receiver operating characteristic analyses and estimation of minimal clinically important differences. This study will contribute to a better understanding of the measurement properties of the FMA in the subacute phase of stroke recovery and support its use in clinical practice and research settings.

Interventions

None listed

Sponsors

Fondazione Don Carlo Gnocchi Onlus
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 years * Diagnosis of stroke with resulting hemiparesis * stroke outcomes with the presence of sensorimotor impairment affecting the upper and/or lower limb * Admission to inpatient rehabilitation in the subacute phase of stroke * Ability and willingness to provide informed consent

Exclusion criteria

* Severe or uncorrected visual or hearing impairments interfering with assessment * Cognitive or language impairments preventing understanding or execution of study procedures * Clinical instability, defined as a Clinical Instability Scale (CIS) score \> 0 * Any medical condition preventing safe participation in rehabilitation or assessments

Design outcomes

Primary

MeasureTime frameDescription
Fugl Meyer AssessmentBaselineA stroke-specific scale evaluating motor function, sensory function, joint range of motion, and pain in upper and lower limbs. It provides detailed assessment of motor impairment severity.
Fugl-Meyer Assessmentafter 3 weeksA stroke-specific scale evaluating motor function, sensory function, joint range of motion, and pain in upper and lower limbs. It provides detailed assessment of motor impairment severity.

Secondary

MeasureTime frameDescription
Modified Barthel IndexBaselineA measure of independence in activities of daily living, assessing the patient's functional ability in everyday tasks.
Motricity IndexBaselineA clinical scale used to assess muscle strength in upper and lower limbs following stroke.
Functional Ambulation CategoryBaselineA clinician-rated scale that evaluates walking ability and level of assistance required for ambulation.
Global Rating of Change (GROC)after 3 weeksA patient-reported scale measuring perceived change in motor function compared to baseline, rated on a 7-point scale from "much worse" to "much better."
Clinical Instability Scale (CIS)BaselineA scale assessing clinical stability based on vital parameters, used to determine eligibility and safety for participation.

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 3, 2026